Evidence map›Paper›PMID 38471107›Full record

ArticleRheumatology (Oxford, England)2024

Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study.

Tiffany Dal Santo, Danielle B Rice, Marie-Eve Carrier, Gabrielle Virgili-Gervais, Brooke Levis, Linda Kwakkenbos, Meira Golberg, Susan J Bartlett, Amy Gietzen, Karen Gottesman and 13 more

Open access · greenAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 4 countries.

Tiffany Dal SantoLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Danielle B RiceDepartment of Psychology, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Gabrielle Virgili-GervaisLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Brooke LevisLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.ORCID 0000-0002-4310-3689
Linda KwakkenbosDepartment of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Meira GolbergLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Susan J BartlettDepartment of Medicine, McGill University, Montreal, QC, Canada.ORCID 0000-0001-9755-2490
Amy GietzenNational Scleroderma Foundation, Tri-State Chapter, Buffalo, NY, USA.
Karen GottesmanNational Scleroderma Foundation, Los Angeles, CA, USA.
Geneviève GuillotSclérodermie Québec, Longueuil, QC, Canada.
Marie HudsonLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Laura K HummersJohns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Baltimore, MD, USA.
Vanessa L MalcarneDepartment of Psychology, San Diego State University, San Diego, CA, USA.
Maureen D MayesDepartment of Internal Medicine, Division of Rheumatology, University of Texas McGovern School of Medicine, Houston, TX, USA.
Luc MouthonService de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Paris, France.
Michelle RichardScleroderma Canada, Hamilton, ON, Canada.
Maureen SauvéScleroderma Canada, Hamilton, ON, Canada.
Robyn K WojeckCollege of Nursing, University of Rhode Island, Kingston, RI, USA.
Marie-Claude GeoffroyDepartment of Psychiatry, McGill University, Montreal, QC, Canada.
Andrea BenedettiDepartment of Medicine, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8314-9497
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.ORCID 0000-0002-5644-8432
SPIN Investigators
Jewish General Hospital · CAMcGill University Health Centre · CAScleroderma Foundation · USSan Diego State University · USDouglas Mental Health University Institute · CAJohns Hopkins University · USUniversity of Rhode Island · USMultiple Sclerosis Society of Canada · CARadboud University Nijmegen · NLSt. Joseph’s Healthcare Hamilton · CAUniversité Paris Cité · FR

Funding

CIHRJewish General HospitalJewish General Hospital FoundationLady Davis Institute for Medical ResearchMcGill UniversityScleroderma CanadaScleroderma Society of OntarioSclérodermie QuébecThe Scleroderma Patient-centered Intervention Network
6 · The paper itself

Abstract

objectivesTo compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and identify associated factors.

methodsScleroderma Patient-centered Intervention Network Cohort participants completed the Physical Function domain of the Patient-Reported Outcomes Measurement Information System Version 2 upon enrolment. Multivariable linear regression was used to assess associations of sociodemographic, lifestyle, and disease-related variables.

resultsAmong 2385 participants, the mean physical function T-score (43.7, SD = 8.9) was ∼2/3 of a standard deviation (SD) below the US general population (mean = 50, SD = 10). Factors associated in the multivariable analysis included older age (-0.74 points per SD years, 95% CI -0.78 to -1.08), female sex (-1.35, -2.37 to -0.34), fewer years of education (-0.41 points per SD in years, -0.75 to -0.07), being single, divorced, or widowed (-0.76, -1.48 to -0.03), smoking (-3.14, -4.42 to -1.85), alcohol consumption (0.79 points per SD drinks per week, 0.45-1.14), BMI (-1.41 points per SD, -1.75 to -1.07), diffuse subtype (-1.43, -2.23 to -0.62), gastrointestinal involvement (-2.58, -3.53 to -1.62), digital ulcers (-1.96, -2.94 to -0.98), moderate (-1.94, -2.94 to -0.93) and severe (-1.76, -3.24 to -0.28) small joint contractures, moderate (-2.10, -3.44 to -0.76) and severe (-2.54, -4.64 to -0.44) large joint contractures, interstitial lung disease (-1.52, -2.27 to -0.77), pulmonary arterial hypertension (-3.72, -4.91 to -2.52), rheumatoid arthritis (-2.10, -3.64 to -0.56) and idiopathic inflammatory myositis (-2.10, -3.63 to -0.56).

conclusionPhysical function is impaired for many individuals with SSc and is associated with multiple disease factors.

Indexed as

Scleroderma, SystemicAdultAgedAge FactorsCohort StudiesCross-Sectional StudiesFemaleHumansLife StyleMaleMiddle AgedPatient Reported Outcome MeasuresSex FactorsSmokingphysical functionPROMIS-29sclerodermasystemic sclerosis

Identifiers

PMID38471107
PMCPMC11443018
OpenAlexW4392686446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.